Authors/Disclosures
|
Sean Grimm, MD
(Rush University)
|
Dr. Grimm has nothing to disclose. |
|
Imane S. Chibane, MD
(Universite De Montreal)
|
No disclosure on file |
|
Brian P. O'Neill, MD, FAAN
(Mayo Clinic)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
David Schiff, MD, FAAN
(Univ of VA, Division of Neuro Oncology)
|
Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Tracy T. Batchelor, MD, MPH
(Brigham and Women's Hospital)
|
Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care. |
|
Ulrich J. Herrlinger
(University of Bonn)
|
No disclosure on file |
|
Edward A. Neuwelt, MD
(Oregon Health Science Univ)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Antonio M. Omuro, MD, FAAN
(Stanford University)
|
Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from Denovo Biopharma. The institution of Dr. Omuro has received research support from Ono Pharmaceutical. The institution of Dr. Omuro has received research support from Servier. The institution of Dr. Omuro has received research support from Nanopharmaceuticals. The institution of Dr. Omuro has received research support from Denovo. |
|
Francesc R. Graus, MD
(IDIBAPS)
|
Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
|
Jeffrey J. Raizer, MD
|
No disclosure on file |
|
James Rubenstein
|
No disclosure on file |
|
Lauren E. Abrey, MD
|
No disclosure on file |